Jinse Pigment Industry Accelerates Again! Annual 9,000-Ton Medical Antibacterial Modified New Material Project Kicks Off

Recently, Jinsesi New Materials (Zhejiang) Co., Ltd.9000-ton Medical Antibacterial Modified New Material ProjectThe official commencement of construction marks Jinse Masterbatch's entry into the high-end medical new materials sector, ushering in a new chapter of high-quality development.

The project is led by Quzhou Changcai Plastic Masterbatch, with Jinse New Materials (Zhejiang) Co., Ltd. as the implementing entity. The company was established on January 30, 2026, with a registered capital of RMB 10 million, focusing on the research and development, production, and sales of antimicrobial modified materials for medical applications, targeting high-end application scenarios such as medical consumables, medical device housings, and sterile packaging.

The project progressed efficiently and orderly: the planning permit was successfully obtained on March 31, laying a compliant foundation for commencement; construction began just two days later, demonstrating the company's rapid execution capability and market confidence.

Antimicrobial modified new materials for medical use are a high-end category at the intersection of medical health and polymer materials, widely used in syringes, infusion sets, surgical instrument packaging, sterile consumables, etc. The core value lies in long-term antibacterial effects, reducing the risk of cross-infection, and meeting the safety upgrade needs of the medical industry. Currently, the demand for medical antimicrobial materials in China continues to grow, with relatively scarce high-end production capacity. After this project goes into production, it will effectively supplement the regional supply and enhance the supporting capabilities of the masterbatch industry in the medical field.

This groundbreaking not only marks a strategic upgrade for Jinsè itself, but also epitomizes Zhejiang’s new materials industry shifting toward high-end, functional, and medical-grade applications. Focused on the medical sector and guided by high standards and stringent safety requirements, the project aims to optimize the local new materials industrial structure and enhance the resilience and competitiveness of the industrial chain.

As the project advances, Jinsè New Materials will further refine its portfolio of color masterbatches and modified materials, strengthen technological R&D and quality control, and provide stable, reliable, high-end material solutions for the medical and healthcare sectors. This will drive the color masterbatch industry’s transformation from generic to specialized and high-end products, supporting the high-quality development of China’s medical new materials industry.

(Partially compiled from Masterbatch Industry Network)